← Back to home

Recent experience

Three recent projects in the region.

Map of the region with the Kovaris markets

Paraguay · 2026

Market entry for a biotech company

A biotech company with a regional footprint needed to define its market entry routes and map the relevant stakeholders. Kovaris reviewed the coverage and purchasing routes for specialty products, the genetics, hemato-oncology and oncology centers, and the opinion leaders in each area. On that basis, the company set its entry plan and its first contacts.

Uruguay · 2025

Prioritizing therapeutic areas and products

A pharmaceutical company was assessing the entry of products from a manufacturing plant in India, across several therapeutic areas, and needed to set priorities. The areas were ranked by number of patients and feasibility of coverage by the Fondo Nacional de Recursos, the competition was analyzed and the registration requirements for each product were reviewed. The result was a prioritized list of molecules and a clear view of the requirements for entering the Uruguayan market.

Argentina · 2026 · Kovaris research

Pricing in hereditary angioedema

A reconstruction, from public sources, of how the price of icatibant moved when a second brand entered and then left the market, and of what the case shows about how a high-cost treatment is purchased and its price defended in Argentina. Published as a white paper in October 2026.

Clients and details anonymized for confidentiality.

The founder's prior experience

More than 50 projects for pharma and biotech in Latin America, Europe and the United States as Principal Consultant at a pharma-focused consultancy (2016 to 2024) and as a consultant at IQVIA for the Southern Cone (2014 to 2016), in strategy, market intelligence, pricing and access, presented to general managers, business unit heads and global brand teams.

Book a call

First step: the decision your team needs to make.

An initial 30-minute call is used to set out the question and the scope; the proposal, with the price and the delivery date, follows in writing.